Quarterly Result21 Jan 2026, 09:52 pm
Dhampur Bio Organics Approves Q3 Results and Explores Mycoprotein Production Opportunity with Planetary SA
AI Summary
Dhampur Bio Organics Ltd. has approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company's board took note of a non-binding term sheet with Planetary SA, Switzerland to explore the opportunity of exclusive production and commercialization of Mycoprotein in India. The arrangement is subject to execution of definitive agreements and fulfillment of conditions.
Key Highlights
- Dhampur Bio Organics approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025.
- The company's board acknowledged a non-binding term sheet with Planetary SA, Switzerland to explore Mycoprotein production and commercialization in India.
- The Mycoprotein arrangement is non-binding and exploratory, subject to definitive agreements and specific conditions.